PAVmed
PAVM
13 hedge funds and large institutions have $2.84M invested in PAVmed in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
182% more capital invested
Capital invested by funds: $1.01M → $2.84M (+$1.83M)
63% more funds holding
Funds holding: 8 → 13 (+5)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$839K |
| 2 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$766K |
| 3 |
LCS
Levin Capital Strategies
New York
|
+$148K |
| 4 |
BlackRock
New York
|
+$61.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$24.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.28M | +$839K | +1,587 | +174% |
|
|
BAM
2
Belpointe Asset Management
Reno,
Nevada
| $743K | +$766K | +1,449 | New |
|
3
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $399K | – | – | – |
|
|
LCS
4
Levin Capital Strategies
New York
| $172K | +$148K | +280 | +500% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $80K | – | – | – |
|
|
6
BlackRock
New York
| $59K | +$61.3K | +116 | New |
|
7
Northern Trust
Chicago,
Illinois
| $25K | – | – | – |
|
|
GWS
8
Glassman Wealth Services
Vienna,
Virginia
| $24K | +$15.3K | +29 | +171% |
|
|
9
Citadel Advisors
Miami,
Florida
| $24K | +$24.8K | +47 | New |
|
|
PAG
10
Private Advisor Group
Morristown,
New Jersey
| $20K | +$8.98K | +17 | +77% |
|
|
MSAM
11
Moloney Securities Asset Management
Manchester,
Missouri
| $13K | – | – | – |
|
12
UBS Group
Zurich,
Switzerland
| $2K | +$2.64K | +5 | New |
|
|
VFA
13
Valeo Financial Advisors
Carmel,
Indiana
| $1K | +$1.06K | +2 | New |
|
PAVM Hedge Fund Activity: Q2 2019 in Review
13 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2019, worth a combined $2.84M — up 182% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PAVM positions and 0 closed out — a net gain of 5 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $839K.
- 13 institutional investors held PAVmed (PAVM) as of Q2 2019, up from 8 in Q1 2019.
- Funds reported $2.84M of PAVmed stock for Q2 2019, up 182% quarter-over-quarter.
- 5 funds opened new PAVmed positions in Q2 2019 and 0 closed out, a net change of +5 holders.
- The largest PAVmed buyer in Q2 2019 was Vanguard Group, an estimated $839K added.
Based on aggregated 13F filings for Q2 2019.